Tag: KEYTRUDA

An experimental cancer vaccine is being developed by Lansdale-centric Merck, with input from Moderna. The project’s mid-stage trials are showing promise in…

Merck, the pharmaceutical giant with sizable operations in West Point outside of Lansdale, and Moderna have announced promising results from a skin cancer mRNA vaccine…

Merck & Co. has raised its revenue outlook, based on a notable rise in sales for 3Q2022. Sabela Ojea reported the revised projections in the…

Merck, the pharmaceutical giant with sizable operations in West Point, is acquiring Acceleron Pharma for around $11.5 billion, according to a staff report from…

Merck, the pharmaceutical giant with sizable operations in West Point, has received another approval for its blockbuster cancer antibody Keytruda, writes Mark Terry for BioSpace…

Drugmaker Merck ‘s posted first quarter revenues of $10.04 billion this week, an increase of 6 percent driven by a jump in sales of…

A new study combining the use of Merck’s Keytruda cancer treatment with Incyte’s immune-oncology drug Epacadostat, is showing promising results in advanced…

Merck has reported excellent quarterly results with profits beating analysts’ estimates, but the company qualified the good news with a future profits warning, write Michael…

Amidst southeast Pennsylvania’s thriving life sciences industry, three companies stood out last year as the most prominent champions of the health and wellbeing of…